Angiotensin-Converting Enzyme Inhibitor Dose Optimization and Its Associated Factors at Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia.
| Publicado en: | Vascular Health & Risk Management Vol. 18; pp. 481 - 494 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
Dove Medical Press Ltd
Jul2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=159328709&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 159328709 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 11766344 6BXM jtl: Vascular Health & Risk Management issn: 11766344 maglogo: N pubinfo: dt: Jul2022 vid: 18 pid: 45064 pub: Dove Medical Press Ltd place: Auckland, <Blank> artinfo: ui: 159328709 10.2147/VHRM.S363051 159328709 ppf: 481 ppct: 13 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Angiotensin-Converting Enzyme Inhibitor Dose Optimization and Its Associated Factors at Felege Hiwot Comprehensive Specialized Hospital, Bahir Dar, Ethiopia. aug: au: Gelaye, Abebech Tewabe Seid, Mohammed Assen Baffa, Lemlem Daniel sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|